Novel Orthosteric/Allosteric Ligands of Cannabinoid Receptors: An Unexpected Pharmacological Profile
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c01778 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Rebecca Ferrisi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Pisa, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Cannabinoid Receptor Agonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Ministero dell?Istruzione, dell?Universit? e della Ricerca, University of Saskatchewan.
Abstract (Originalsprache)
The design of dualsteric/bitopic receptor ligands as compounds capable of simultaneously interacting with both the orthosteric and an allosteric binding site has gained importance to achieve enhanced receptor specificity and minimize off-target effects. In this work, we reported the synthesis and biological evaluation of a new series of compounds, namely, the RF series, obtained by chemically combining the CB1R ago-positive allosteric modulators (PAM) GAT211 with the cannabinoid receptors (CBRs) orthosteric agonist FM6b . Therefore, RF compounds were designed as dualsteric/bitopic ligands for h CB1R with the aim of obtaining stronger h CB1R agonists or ago-PAMs, with improved receptor subtype selectivity and reduction of central side effects. Unexpectedly, in vitro assays on h CB1R indicated RF compounds were inverse agonists/antagonists, exhibiting different profiles compared to those of parent compounds FM6b and GAT211 and, furthermore, two compounds behaved as h CB2R PAMs. The unpredictable change in the function of these new ligands suggests that the function of cannabinoids is not simply predicted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
- Department of Pathology, University of Pisa, 56126 Pisa, Italy.
- College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
- Department of Pharmaceutical Sciences, University of Milan, 20133 Milan, Italy.
ORCID-Profile: Anna Maria Piras, Simona Rapposelli, Clementina Manera
Förderung
- Ministero dell?Istruzione, dell?Universit? e della Ricerca
- University of Saskatchewan
Zitieren
APA
Ferrisi, R., Polini, B., Smolyakova, A. M., Migone, C., Giammattei, G., Banti, M., Baron, G., Della Vedova, L., Chiellini, G., Gado, F., Piras, A. M., Rapposelli, S., Laprairie, R. B., Ortore, G., & Manera, C. (2025). Novel Orthosteric/Allosteric Ligands of Cannabinoid Receptors: An Unexpected Pharmacological Profile. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01778
Vancouver
Ferrisi R, Polini B, Smolyakova AM, Migone C, Giammattei G, Banti M, et al. Novel Orthosteric/Allosteric Ligands of Cannabinoid Receptors: An Unexpected Pharmacological Profile. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c01778
BibTeX
@article{Ferrisi2025,
author = {Ferrisi, Rebecca and Polini, Beatrice and Smolyakova, Anna Maria and Migone, Chiara and Giammattei, Gaia and Banti, Matteo and Baron, Giovanna and Della Vedova, Larissa and Chiellini, Grazia and Gado, Francesca and Piras, Anna Maria and Rapposelli, Simona and Laprairie, Robert B and Ortore, Gabriella and Manera, Clementina},
title = {Novel Orthosteric/Allosteric Ligands of Cannabinoid Receptors: An Unexpected Pharmacological Profile},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c01778}
}
EUVIMED